How can we all best use evidence?

The Academy of Medical Sciences published a report in June 2017 examining how we can all best use evidence to judge the potential benefits and harms of medicines. 

To find out more about the report, visit our dedicated microsite.

In recent years, the evidence underlying decisions about treatment options has been subject to debate, for example on using statins to prevent heart disease and stroke, Tamiflu to treat influenza, and HRT to treat the symptoms of the menopause. How evidence is collected and analysed has been part of this debate, as have broader discussions of issues such as medicalisation (or the reliance on drugs over lifestyle changes) and conflicts of interest in the way that evidence collection is funded and/or analysed.

The Academy’s report, ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’, explores these issues further. It concludes that scientific evidence should be at the heart of decisions about the use of medicines, as it is open to check and challenge. To enable this, the report calls for improvements to:

  • The generation of scientific evidence to ensure it is robust, reliable and relevant to patients.
  • The trustworthiness of scientific evidence so that information is disclosed in an accessible, assessable, and usable manner.
  • The communication of evidence to ensure it is presented in a clear, accurate and actionable way.

Making progress on these fronts will require a collective effort from a wide range of stakeholders across the biomedical community.

Please visit our dedicated microsite to view further summary animations about the report.

Evidence feeding into the project

The report brings together a series of sub-projects that considered elements relating to:

Evidence that has contributed to this report, including workshop reports from the sub-projects are available in the evidence repository for this project.

Financial contributions towards the project

Arthritis Research UK, the British Heart Foundation (through a Strategic Funding Award), the British Pharmacological Society, the British Society for Immunology, the Medical Research Council, the Naji Foundation and the National Institute of Health Research Health Technology Assessment Programme kindly provided financial contributions towards this work. Funding from a core grant from the Department for Business, Energy and Industrial Strategy to the Academy was also used to support this project. This was an independent project that had the support of the Chief Medical Officer. Funders did not approve the conclusions and recommendations and were not sent a draft of the report for approval.

   www.arthritisresearchuk.org

    www.bhf.org.uk

  www.bps.ac.uk

 www.immunology.org

  www.mrc.ac.uk

 najifoundation.org

   www.nihr.ac.uk

Staff leads


Anniversary Fellows Meeting 2018

Book Now

Joint symposium on mental health and addiction: A discussion, exchange and sharing of perspectives

Book Now

South-East Regional Annual Lecture 2018, Oxford, 3 December

Book Now
View more
 
 
 
 
 
 
FB Twitter Instagram Youtube